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Eur J Vasc Endovasc Surg (2010) 39, 654e655CORRESPONDENCELetter to EditorDear Sir,
Your timely survey1 emphasised the use of oral antiplatelet
agents in the perioperative period of carotid endarterec-
tomy (CEA). There is a growing realization of the important
role of transcranial Doppler and intravenous antiplatelet
therapy in the control of platelet microemboli and associ-
ated perioperative strokes.2 Pre-operatively, recurrent and
frequent symptoms may be due to superimposed platelet
thrombus in unstable carotid plaque, analogous to the
acute coronary syndrome.2 Indeed, IV Dextrans have been
used to reduce the microembolic load, control symptoms
and to allow timely progress to CEA on the next elective
list.3
Although your survey questioned respondents on the
use of IV dextran perioperatively, we note that its use is
only mentioned in the intraoperative results section. In
fact, most of the literature on IV Dextrans’ use has been
in the pre- and post-operative period.3,4 Dextrans,
however have been associated with significant side-
effects.4 More recently Tirofiban, a cardiac glycoprotein
IIb/IIIa inhibitor, has been assessed in carotid patients
with TCD detected microemboli.5 Both pre- and
post-operative microemboli were rapidly and safely
controlled.
Yours sincerely,
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Comment On: “A 15-Year Experience with Combined
Vascular Reconstruction and Free Flap Transfer for
Limb-Salvage”, C. Randon, B. Jacobs, F. De Ryck,
K. Van Landuyt, F. Vermassen Eur. J Vasc Endovasc
Surg 2009;38(3):338e345Dear Editor,
Randon et al. recently published the long-term Belgian
experience in combining bypass grafting and microvascular
free tissue transfer to revascularise severely ischaemic feet
with large tissue defects with poor healing potential.1 We
share the joy from their results, but not necessarily from
the way our results were used as comparison. Our patients
did not have less diabetes, smaller lesions nor poorer
results.2 Most of the patients had diabetes in both series,
70.5% in their, and 73% in our series, not 25%, which was the
proportion of the type I diabetic patients.DOI of original article: 10.1016/j.ejvs.2009.06.005.
Table 1 Corrected comparison of the two largest European series on combined vascular reconstruction and FFT for limb-
salvage.
Author year N Diabetes % Patient survival at 5 yrs Limb salvage at 5 yrs
Tukiainen et al. 20062 81 73% 63% 66%
Randon et al. 20091 78 70.5% 51% 70%
Correspondence 655Only large defects may need coverage, especially if
deep and in vulnerable location. We found that increased
risk for amputation was associated with location of the
ulcer in the heel area, and diameter exceeding 10 cm
(corresponding roughly surface area of 50e75 cm2), in our
material 54% of the tissue defects exceeded this measure.
We did not cover minor defects smaller than 10 cm2 though
the article at issue so stated.1
We are pleased to present the results in a redressed
form (Table 1) but including only these two series, largest
available in Europe so far. The results are quite identical
and give us an excellent means to further emphasize the
feasibility of combined microvascular free flap and vascular
reconstruction in selected group of patients.References
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